Cartesian Therapeutics, Inc.: capex
| Value | {"amount": 456000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-06-30 |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:00.935149+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b346b837-f071-445d-9b0c-1086af606378
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-18-000052Retrieved: 2026-08-19T14:22:00.935149+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/capex/2018-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b346b837-f071-445d-9b0c-1086af606378
History
- no predecessors — first report